Sep 2026
Radium-223 therapy in metastatic castration-resistant prostate cancer: baseline predictors of treatment completion and survival in a reimbursement-regulated Taiwanese cohort.
Hsi-Chen Tsai, Jing-Ren Tseng, Feng-Yuan Liu et al.
· Annals of Nuclear Medicine · 0 citations